Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L, Riccioni T, Marcellini M, Vesci L, Chiarucci I, Efrati D, Potenza D, Scolastico C, Manzoni L, Lombardo K, Stasi MA, Orlandi A, Ciucci A, Nico B, Ribatti D, Giannini G, Presta M, Carminati P, Pisano C.
Belvisi L, et al. Among authors: stasi ma.
Mol Cancer Ther. 2005 Nov;4(11):1670-80. doi: 10.1158/1535-7163.MCT-05-0120.
Mol Cancer Ther. 2005.
PMID: 16275988